PlainRecalls
FDA Drug Moderate Class II Ongoing

Morphine Sulfate Extended-Release Tablets, 100 mg, 100-count bottles, Rx Only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901. Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512. NDC 63304-452-01

Reported: March 12, 2025 Initiated: February 6, 2025 #D-0249-2025

Product Description

Morphine Sulfate Extended-Release Tablets, 100 mg, 100-count bottles, Rx Only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901. Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512. NDC 63304-452-01

Reason for Recall

Failed Dissolution Specifications

Details

Units Affected
9840 bottles
Distribution
Nationwide within in the USA.
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Morphine Sulfate Extended-Release Tablets, 100 mg, 100-count bottles, Rx Only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901. Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512. NDC 63304-452-01. Recalled by SUN PHARMACEUTICAL INDUSTRIES INC. Units affected: 9840 bottles.
Why was this product recalled?
Failed Dissolution Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on March 12, 2025. Severity: Moderate. Recall number: D-0249-2025.